| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 6.4% | $443,369,062 | 2,007,193 | The Vanguard Group | 31 Dec 2025 | |||
| BIOTECHNOLOGY VALUE FUND L P | 4.4% | -16% | $113,871,586 | -$21,545,460 | 1,189,165 | -16% | BVF PARTNERS L P/IL | 15 Oct 2025 |
| BlackRock, Inc. | 4.6% | -15% | $111,424,214 | +$5,356,584 | 1,163,607 | +5.1% | BlackRock, Inc. | 30 Sep 2025 |
| Adage Capital Management, L.P. | 5% | -45% | $55,594,000 | +$5,559,400 | 1,100,000 | +11% | Adage Capital Management, L.P. | 30 Jun 2025 |
| Paradigm Biocapital Advisors LP | 3.3% | -38% | $92,041,065 | -$16,034,916 | 961,164 | -15% | Paradigm BioCapital Advisors LP | 30 Sep 2025 |
| Venrock Healthcare Capital Partners III, L.P. | 3.2% | -67% | $32,299,508 | -$23,243,750 | 639,088 | -42% | Venrock Healthcare Capital Partners III, L.P. | 30 Jun 2025 |
| Commodore Capital LP | 2% | -58% | $56,019,600 | -$56,498,400 | 585,000 | -50% | Commodore Capital LP | 30 Sep 2025 |
| Point72 Asset Management, L.P. | 1.4% | -80% | $99,621,000 | -$249,731,915 | 450,000 | -71% | Point72 Asset Management, L.P. | 31 Dec 2025 |
As of 31 Dec 2025, 243 institutional investors reported holding 33,274,995 shares of Cidara Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CDTX). This represents 104% of the company’s total 32,142,857 outstanding shares.
The largest institutional shareholders of Cidara Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CDTX) together control 68% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 10% | 3,365,523 | 0% | 7.6% | $743,410,375 |
| VANGUARD GROUP INC | 6.2% | 2,007,193 | +63% | 0.01% | $443,368,862 |
| BlackRock, Inc. | 5.2% | 1,680,662 | +44% | 0.01% | $371,241,429 |
| HBK INVESTMENTS L P | 3.9% | 1,260,000 | 3% | $278,321,400 | |
| FIL Ltd | 3.9% | 1,257,574 | 0.21% | $277,785,521 | |
| UBS Group AG | 3.3% | 1,074,924 | +127% | 0.05% | $237,439,963 |
| Darwin Global Management, Ltd. | 3.1% | 997,196 | 0% | 4.5% | $220,180,877 |
| Vivo Capital, LLC | 3% | 956,670 | -27% | 14% | $211,318,836 |
| STATE STREET CORP | 2.8% | 884,374 | +14% | 0.01% | $195,349,373 |
| Jefferies Financial Group Inc. | 2.4% | 766,520 | +110% | 1.4% | $169,316,603 |
| Paradigm Biocapital Advisors LP | 2.4% | 759,565 | -21% | 4.5% | $167,780,313 |
| Balyasny Asset Management L.P. | 2.1% | 672,890 | +241% | 0.28% | $148,634,672 |
| Glazer Capital, LLC | 2% | 650,191 | 3.8% | $143,621,000 | |
| Pentwater Capital Management LP | 1.8% | 565,000 | 0.9% | $124,802,850 | |
| MORGAN STANLEY | 1.7% | 542,722 | +44% | 0.01% | $119,881,979 |
| Beryl Capital Management LLC | 1.6% | 522,138 | 12% | $115,335,063 | |
| GEODE CAPITAL MANAGEMENT, LLC | 1.6% | 520,591 | +29% | 0.01% | $115,018,309 |
| MILLENNIUM MANAGEMENT LLC | 1.6% | 509,647 | +171% | 0.08% | $112,575,926 |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 1.5% | 477,527 | +267% | 3% | $105,480,939 |
| MAVERICK CAPITAL LTD | 1.4% | 455,978 | +9.2% | 1.1% | $100,720,980 |
| FARALLON CAPITAL MANAGEMENT LLC | 1.2% | 382,800 | -25% | 0.49% | $84,556,692 |
| GOLDMAN SACHS GROUP INC | 1.2% | 377,718 | +40% | 0.01% | $83,434,129 |
| Qube Research & Technologies Ltd | 1.1% | 358,432 | +899% | 0.11% | $79,174,044 |
| CITIGROUP INC | 1.1% | 348,421 | +17795% | 0.05% | $76,962,715 |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 0.98% | 315,474 | 8.2% | $69,685,052 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 33,274,995 | $7,347,397,402 | +$1,521,365,392 | $220.89 | 243 |
| 2025 Q3 | 32,486,735 | $3,110,319,924 | +$679,666,083 | $95.76 | 167 |
| 2025 Q2 | 25,911,048 | $1,262,611,204 | +$803,273,260 | $48.71 | 106 |
| 2025 Q1 | 9,559,359 | $205,909,478 | +$57,592,846 | $21.54 | 45 |
| 2024 Q4 | 6,873,669 | $183,637,032 | +$100,865,295 | $26.88 | 40 |
| 2024 Q3 | 3,308,428 | $35,565,026 | +$20,361,776 | $10.75 | 27 |
| 2024 Q2 | 1,412,361 | $16,863,937 | +$16,863,734 | $11.94 | 25 |